Caduceus News - Chirurgische Klinik St. Josef-Hospital Bochum

B e s t r a h l u n g s v e rf a h ren über MRTist im Ve rgleich kostengünstigerund effektiver (44). Eine prospektiveeuropäische Multizenterstudiemit Ziel einer MRT- b a s i e rt e nPatientenselektion zur neoadjuvantenStrahlentherapie, dieM.E.R.C.U.R.Y.- Studie, wurde 2002initiiert (45).Erste Ergebnisse legen nahe, dassdieses Verfahren das histopathologischeTumorstadium akkurat vorhe rzusagen vermag (46). Somitw i rd sich die Anzahl unnötigerVorbehandlungen mittels Radiatiobeim Rektumkarzinom re d u z i e re nlassen. Durch die Kombination vondiagnostischer MRT und TME-Technik wird sich daher das outcomevon Patienten mitK a rzinomen des Rektums weiterverbessern.Literaturverzeichnis:1. Breen RE, Garnjobst W. Surgical proceduresfor carcinoma of the rectum. Ahistorical re v i e w. Dis Colon Rectum1983; 26:680-5.2. Goligher JC, Lee PW, Macfie J,Simpkins KC, Lintott DJ. Experiencewith the Russian model 249 suture gunfor anastomosis of the rectum. SurgGynecol Obstet 1979; 148:516-24.3. Heald RJ. To w a rds fewer colostomies--theimpact of circular staplingdevices on the surgery of rectal cancerin a district hospital. Br J Surg 1980;67:198-200.4. Phillips RK, Hittinger R, Blesovsky L,Fry JS, Fielding LP. Local recurrence following'curative' surg e ry for larg ebowel cancer: II. The rectum and rectosigmoid.Br J Surg 1984; 71:17-20.5. Rich T, Gunderson LL, Lew R,Galdibini JJ, Cohen AM, Donaldson G.Patterns of recurrence of rectal cancerafter potentially curative surg e ry.Cancer 1983; 52:1317-29.6. Localio SA, Eng K, Coppa GF.Abdominosacral resection for midrectalcancer. A fifteen-year experience. AnnSurg 1983; 198:320-4.7. Hermanek P, Wiebelt H, Staimmer D,Riedl S. Prognostic factors of rectumcarcinoma--experience of the GermanM u l t i c e n t re Study SGCRC. Germ a nStudy Group Colo-Rectal Carcinoma.Tumori 1995; 81:60-4.8. Holm T, Cedermark B, Rutqvist LE.Local recurrence of rectal adenocarcinomaafter 'curative' surgery with andwithout preoperative radiotherapy. Br JSurg 1994; 81:452-5.9. Krook JE, Moertel CG, GundersonLL, et al. Effective surgical adjuvant therapyfor high-risk rectal carcinoma. NEngl J Med 1991; 324:709-15.10.Heald RJ, Husband EM, Ryall RD.The mesorectum in rectal cancer surgery--theclue to pelvic recurrence? Br JSurg 1982; 69:613-6.11.Heald RJ, Ryall RD. Recurrence andsurvival after total mesorectal excisionfor rectal cancer. Lancet 1986; 1:1479-82.12.Heald RJ, Moran BJ, Ryall RD,Sexton R, MacFarlane JK. Rectal cancer:the Basingstoke experience of totalmesorectal excision, 1978-1997. ArchSurg 1998; 133:894-9.13.Hill GL, Rafique M. Extrafascial excisionof the rectum for rectal cancer. BrJ Surg 1998; 85:809-12.14.Ross A, Rusnak C, Weinerman B, etal. Recurrence and survival after surgicalmanagement of rectal cancer. Am JSurg 1999; 177:392-5.15.Bjerkeset T, Edna TH. Rectal cancer:the influence of type of operation onlocal recurrence and survival. Eur JSurg 1996; 162:643-8.16.Eu KW, Seow-Choen F, Ho JM, HoYH, Leong AF. Local recurrence followingrectal resection for cancer. J RColl Surg Edinb 1998; 43:393-6.17.Dixon AR, Maxwell WA, Holmes JT.Carcinoma of the rectum: a 10-yearexperience. Br J Surg 1991; 78:308-11.18.Enker WE, Thaler HT, Cranor ML,Polyak T. Total mesorectal excision inthe operative treatment of carcinoma ofthe rectum. J Am Coll Surg 1995;181:335-46.19.Heald RJ. Total mesorectal excision.The new European gold standard. GChir 1998; 19:253-5.20.Kapiteijn E, Putter H, van de VeldeCJ. Impact of the introduction and trainingof total mesorectal excision onrecurrence and survival in rectal cancerin The Netherlands. Br J Surg 2002;89:1142-9.21.Wibe A, Moller B, Norstein J, et al. Anational strategic change in treatmentpolicy for rectal cancer--implementationof total mesorectal excision as routinetreatment in Norway. A national audit.Dis Colon Rectum 2002; 45:857-66.22.Havenga K, Maas CP, DeRuiter MC,Welvaart K, Trimbos JB. Avoiding longtermdisturbance to bladder and sexualfunction in pelvic surgery, particularlywith rectal cancer. Semin Surg Oncol2000; 18:235-43.23.Sugihara K, Moriya Y, Akasu T, FujitaS. Pelvic autonomic nerve preservationfor patients with rectal carc i n o m a .Oncologic and functional outcome.Cancer 1996; 78:1871-80.24.Havenga K, Enker WE, McDermott K,Cohen AM, Minsky BD, Guillem J. Maleand female sexual and urinary functionafter total mesorectal excision withautonomic nerve preservation for carcinomaof the rectum. J Am Coll Surg1996; 182:495-502.25.Arbman G, Nilsson E, Hallbook O,Sjodahl R. Local recurrence followingtotal mesorectal excision for rectal cancer.Br J Surg 1996; 83:375-9.26.Hainsworth PJ, Egan MJ, CunliffeWJ. Evaluation of a policy of total mesorectalexcision for rectal and rectosigmoidcancers. Br J Surg 1997; 84:652-6.27.Carlsen E, Schlichting E, Guldvog I,Johnson E, Heald RJ. Effect of the introductionof total mesorectal excision forthe treatment of rectal cancer. Br J Surg1998; 85:526-9.28.Heald RJ, Karanjia ND. Results ofradical surgery for rectal cancer. World JSurg 1992; 16:848-57.29.Karanjia ND, Corder AP, HoldsworthPJ, Heald RJ. Risk of peritonitis and fatalsepticaemia and the need to defunctionthe low anastomosis. Br J Surg 1991;78:196-8.30.Heald RJ. The 'Holy Plane' of rectalsurgery. J R Soc Med 1988; 81:503-8.31.Heald RJ, Moran BJ, Brown G,Daniels IR. Optimal total mesore c t a lexcision for rectal cancer is by dissectionin front of Denonvilliers' fascia. Br JSurg 2004; 91:121-3.32.Z'Graggen K, Maurer CA, BuchlerM W. Transverse coloplasty pouch. Anovel neorectal re s e rv o i r. Dig Surg1999; 16:363-6.14